tiprankstipranks
Trending News
More News >
Kezar Life Sciences Inc (DE:2KZ0)
FRANKFURT:2KZ0
Germany Market

Kezar Life Sciences (2KZ0) Stock Forecast & Price Target

Compare
1 Followers
See the Price Targets and Ratings of:

2KZ0 Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Kezar
Life Sciences
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

2KZ0 Stock 12 Month Forecast

There Are No Analyst Ratings for DE:2KZ0 In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

2KZ0 Financial Forecast

2KZ0 Earnings Forecast

Next quarter’s earnings estimate for 2KZ0 is -€1.11 with a range of -€1.25 to -€0.96. The previous quarter’s EPS was -€1.29. 2KZ0 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year 2KZ0 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 2KZ0 is -€1.11 with a range of -€1.25 to -€0.96. The previous quarter’s EPS was -€1.29. 2KZ0 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year 2KZ0 has Performed in-line its overall industry.

2KZ0 Sales Forecast

Next quarter’s sales forecast for 2KZ0 is €0.00 with a range of €0.00 to €0.00. The previous quarter’s sales results were €0.00. 2KZ0 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year 2KZ0 has Performed in-line its overall industry.
Next quarter’s sales forecast for 2KZ0 is €0.00 with a range of €0.00 to €0.00. The previous quarter’s sales results were €0.00. 2KZ0 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year 2KZ0 has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on DE:2KZ0
Wells Fargo
Wells Fargo
€5.92€4.23
Hold
-17.91%
Downside
Reiterated
10/17/25
Kezar Life Sciences price target lowered to $5 from $7 at Wells FargoKezar Life Sciences price target lowered to $5 from $7 at Wells Fargo
Jefferies
€15.22€5.92
Hold
14.93%
Upside
Downgraded
10/17/25
Kezar Life Sciences Faces Uncertainty with Hold Rating Amid FDA Setback and Strategic Alternatives Exploration
William Blair Analyst forecast on DE:2KZ0
William Blair
William Blair
Hold
Downgraded
10/17/25
William Blair downgrades Kezar Life Sciences (KZR) to a Hold
TD Cowen Analyst forecast on DE:2KZ0
TD Cowen
TD Cowen
Buy
Reiterated
08/14/25
Positive Phase 2 Trial Results and Regulatory Progress Bolster Buy Rating for Kezar Life Sciences
H.C. Wainwright Analyst forecast on DE:2KZ0
H.C. Wainwright
H.C. Wainwright
Hold
Reiterated
07/16/25
Cautious Hold on Kezar Life Sciences Amid Zetomipzomib Developments and Market Uncertainties
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on DE:2KZ0
Wells Fargo
Wells Fargo
€5.92€4.23
Hold
-17.91%
Downside
Reiterated
10/17/25
Kezar Life Sciences price target lowered to $5 from $7 at Wells FargoKezar Life Sciences price target lowered to $5 from $7 at Wells Fargo
Jefferies
€15.22€5.92
Hold
14.93%
Upside
Downgraded
10/17/25
Kezar Life Sciences Faces Uncertainty with Hold Rating Amid FDA Setback and Strategic Alternatives Exploration
William Blair Analyst forecast on DE:2KZ0
William Blair
William Blair
Hold
Downgraded
10/17/25
William Blair downgrades Kezar Life Sciences (KZR) to a Hold
TD Cowen Analyst forecast on DE:2KZ0
TD Cowen
TD Cowen
Buy
Reiterated
08/14/25
Positive Phase 2 Trial Results and Regulatory Progress Bolster Buy Rating for Kezar Life Sciences
H.C. Wainwright Analyst forecast on DE:2KZ0
H.C. Wainwright
H.C. Wainwright
Hold
Reiterated
07/16/25
Cautious Hold on Kezar Life Sciences Amid Zetomipzomib Developments and Market Uncertainties
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Kezar Life Sciences

3 Months
xxx
Success Rate
8/18 ratings generated profit
44%
Average Return
-6.34%
reiterated a xxx
rating 7 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 44.44% of your transactions generating a profit, with an average return of -6.34% per trade.
1 Year
Phil NadeauTD Cowen
Success Rate
9/18 ratings generated profit
50%
Average Return
-0.04%
reiterated a buy rating 7 months ago
Copying Phil Nadeau's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -0.04% per trade.
2 Years
xxx
Success Rate
10/18 ratings generated profit
56%
Average Return
+21.57%
reiterated a xxx
rating 7 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 55.56% of your transactions generating a profit, with an average return of +21.57% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

2KZ0 Analyst Recommendation Trends

Rating
Jul 25
Aug 25
Oct 25
Dec 25
Jan 26
Strong Buy
0
0
0
0
0
Buy
3
5
3
2
0
Hold
4
4
6
5
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
7
9
9
7
5
In the current month, 2KZ0 has received 0 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. 2KZ0 average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

2KZ0 Stock Forecast FAQ

What is DE:2KZ0’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:2KZ0’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:2KZ0, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Kezar Life Sciences Inc a Buy, Sell or Hold?
      Currently, no data Available
      What is Kezar Life Sciences Inc’s share price target?
      Currently, no data Available
      What do analysts say about Kezar Life Sciences Inc?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Kezar Life Sciences Inc?
      To buy shares of DE:2KZ0, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.